| abstract |
The present invention relates to an improved method for preparing a sterile topical ophthalmic aqueous nanosuspension of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspension can be used to treat ocular inflammatory conditions such as blepharitis, posterior blepharitis, meibomian gland dysfunction and dry eye by topical application of the nanosuspension to the eyelids, eyelashes and to the eyelid margin. |